Trade BCYC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bicycle Therapeutics plc American Depositary Shares (BCYC) is trading at US$3.86, up 0.78% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$305.87M. Over the past 52 weeks, BCYC has traded between US$3.75 and US$9.16. On Syfe you can trade BCYC with $0 commission and add it to your watchlist.
| Previous close | US$3.83 |
|---|---|
| Market cap | US$305.87M |
| 52-week range | US$3.75 – US$9.16 |
| Volume | 621.16K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bicycle Therapeutics plc American Depositary Shares
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Year: 2019
Oppenheimer Adjusts Price Target on Bicycle Therapeutics to $11 From $36, Maintains Outperform Rating
Jul 31, 1:31 PM · MT Newswires
Oppenheimer Adjusts Bicycle Therapeutics PT to $36 From $44, Maintains Outperform Rating
Mar 18, 12:37 PM · MT Newswires
RBC Cuts Price Target on Bicycle Therapeutics to $7 From $11, Keeps Sector Perform, Speculative Risk
Mar 18, 10:56 AM · MT Newswires
Stay on top of BCYC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
